Choksi Laboratories Ltd
05 Oct 2026 12:00 AM
Choksi Laboratories Limited confirmed regulatory compliance for the quarter ended September 30, 2026,
Choksi Laboratories Limited, on October 5, 2026, submitted a certificate to the BSE Limited concerning the compliance of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by Ankit Consultancy Pvt. Ltd., the company`s registrar and share transfer agent.
Choksi Laboratories Ltd
26 Sep 2026 12:00 AM
Choksi Laboratories closes trading window for insiders starting October 1, 2026,
Choksi Laboratories Limited informed the BSE Limited that it will close the trading window for its shares for all designated persons, their immediate relatives, and connected persons, starting October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half year ended September 30, 2026. The company also stated that it has complied with SEBI circulars dated August 5, 2022, July 19, 2023, and April 21, 2025, regarding trading window closure and freezing of PAN at the security level.
Choksi Laboratories Ltd
24 Sep 2026 12:00 AM
Choksi Laboratories to allot warrants to promoters, increasing their stake to 34.76%,
Choksi Laboratories Limited plans a preferential allotment of 350,000 convertible warrants to promoters Sunil Kumar Choksi, Himika Choksi, and Stela Choksi, increasing the promoter group’s stake from 31.48% to 34.76%. The allotment, compliant with the Companies Act, 2013, SEBI regulations, and BSE listing requirements, will be conducted for cash and is not expected to trigger takeover regulations. While the issue and conversion prices were not disclosed, the move will dilute existing shareholders’ ownership. The warrants and resulting shares will be subject to lock-in periods, and the company’s management and control will remain unchanged. The board recommends shareholder approval, and relevant documents are available for inspection at the company’s registered office.
Choksi Laboratories Ltd
14 Sep 2026 12:00 AM
Choksi Laboratories plans to raise funds via equity shares and warrants, pending approvals,
Choksi Laboratories Limited will hold a meeting of its Board of Directors on September 19, 2026, to consider and approve a proposal for raising funds through the issue of equity shares and/or other equity-linked or convertible securities, including warrants, via a preferential issue or other permissible modes, subject to member and regulatory approvals.
Choksi Laboratories Ltd
13 Aug 2026 12:00 AM
Choksi Laboratories re-appointed Himika Choksi as Whole Time Director for five years,
Choksi Laboratories Limited announced that its board of directors re-appointed Ms. Himika Choksi as a Whole Time Director for a further period of five years, effective April 1, 2027, subject to shareholder approval at the company`s upcoming Annual General Meeting. Ms. Choksi, who is a Promoter member of the company, is the daughter of Managing Director Sunil Choksi and Whole Time Director Stela Choksi, and the sister of Whole Time Director Vyangesh Choksi.
Subscribe for our
newsletter
newsletter
HSL Mobile App